overwatchtrader
Short

ACOR Bio "buy the rumor sell the news" event

NASDAQ:ACOR   ACORDA THERAPEUTICS INC
NASDAQ:ACOR

Future Catalyst:
October 2018 10/31/2018
Phase 2 data likely due October 2018.

Market cap: 942M. Float: 46M

Company Notes - Negative income with poor performance. 4 Products non of which has passed P3.

Watching for volume to push stock through consolidation and climb into the Phase 2 data results and sell off. Investors have little hope for this stock and any remaining longs underwater will be looking for any run up into this catalyst as an opportunity to sell.
Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features Pricing House Rules Moderators Website & Broker Solutions Widgets Charting Solutions Get Help Feature Request Blog & News FAQ Wiki Twitter
Profile Profile Settings Account and Billing Get Help Ideas Published Followers Following Private Messages Chat Sign Out